BOPU

Hopewell Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, that specializes in developing synthetic lipid-based drug delivery systems. Founded in 2018, the company focuses on creating biodegradable lipid nanoparticles designed for the delivery of nucleic acids in gene therapy and gene editing applications. Their innovative technology aims to enhance the efficacy of genomic medicines, providing healthcare professionals with improved tools for immunotherapy and related therapies. Through its advancements in drug delivery, Hopewell Therapeutics seeks to facilitate the safe and effective administration of cutting-edge treatments to patients.

CytoCan Corp. is a biotechnology company dedicated to the research and development of innovative cancer therapies. The company specializes in creating multi-specific fusion protein drugs through its modular platform technology, which enables the production of proteins that target cancer cells with multiple functions. By identifying unmet medical needs and focusing on difficult-to-treat cancers, CytoCan designs targeted immune therapies aimed at enhancing patients' ability to combat cancer. Through its advanced approach, the company seeks to make significant contributions to the field of oncology and improve treatment outcomes for patients facing challenging cancer diagnoses.

MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.

Kula Bio, Inc. is focused on developing innovative biological solutions for modern agriculture. Founded in 2018 and based in Somerville, Massachusetts, the company specializes in the production of organic biofertilizers using nitrogen-fixing microbes charged with renewable energy. By enhancing natural microbial processes, Kula Bio aims to create affordable and sustainable fertilization methods that enable farmers to increase their yields while promoting environmental stewardship. The company's approach seeks to disrupt traditional synthetic fertilizers, bridging the gap between effective agricultural practices and the responsible management of natural resources.

Kula Bio, Inc. is focused on developing innovative biological solutions for modern agriculture. Founded in 2018 and based in Somerville, Massachusetts, the company specializes in the production of organic biofertilizers using nitrogen-fixing microbes charged with renewable energy. By enhancing natural microbial processes, Kula Bio aims to create affordable and sustainable fertilization methods that enable farmers to increase their yields while promoting environmental stewardship. The company's approach seeks to disrupt traditional synthetic fertilizers, bridging the gap between effective agricultural practices and the responsible management of natural resources.